Multi-Drug Therapy Including Immune Checkpoint Inhibitors in Ovarian Cancer
Received Date: Dec 20, 2019 / Accepted Date: Jan 06, 2020 / Published Date: Jan 13, 2020
Abstract
Ovarian cancer has the worst prognosis among gynecological cancers. Since only a few cases of ovarian cancer could be treated effectively with immune checkpoint inhibitor monotherapy, to improve the prognosis of ovarian cancer, multi-drug therapy including immune checkpoint inhibitors is necessary. In this short commentary, we highlight the need for studies on novel treatment strategies.
Keywords: Microsatellite instability; Ovarian cancer; Immune checkpoint inhibitor; Immunohistochemistry; Mismatch repair protein
Citation: Yamashita H, Nakayama K, Kyo S (2019) Multi-Drug Therapy Including Immune Checkpoint Inhibitors in Ovarian Cancer. Diagn Pathol Open 4: 159. Doi: 10.4172/2476-2024.1000159
Copyright: © 2020 Yamashita H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 2467
- [From(publication date): 0-2019 - Nov 19, 2024]
- Breakdown by view type
- HTML page views: 1820
- PDF downloads: 647
